203 related articles for article (PubMed ID: 22395816)
1. Management of chronic myeloid leukemia in childhood.
Suttorp M; Eckardt L; Tauer JT; Millot F
Curr Hematol Malig Rep; 2012 Jun; 7(2):116-24. PubMed ID: 22395816
[TBL] [Abstract][Full Text] [Related]
2. Targeted chronic myeloid leukemia therapy: Seeking a cure.
Fausel C
Am J Health Syst Pharm; 2007 Dec; 64(24 Suppl 15):S9-15. PubMed ID: 18056932
[TBL] [Abstract][Full Text] [Related]
3. Initial treatment for patients with CML.
Goldman JM
Hematology Am Soc Hematol Educ Program; 2009; ():453-60. PubMed ID: 20008231
[TBL] [Abstract][Full Text] [Related]
4. [Management of chronic myeloid leukemia].
Kubuki Y
Rinsho Ketsueki; 2008 Oct; 49(10):1401-10. PubMed ID: 18833925
[No Abstract] [Full Text] [Related]
5. 3. Imatinib therapy in chronic myelogenous leukemia.
Jinnai I
Intern Med; 2007; 46(2):95-7. PubMed ID: 17220607
[No Abstract] [Full Text] [Related]
6. [Chronic myeloid leukemia 2008].
Cervantes F
Med Clin (Barc); 2008 Nov; 131(17):658-9. PubMed ID: 19087793
[No Abstract] [Full Text] [Related]
7. Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.
Wu J; Meng F; Kong LY; Peng Z; Ying Y; Bornmann WG; Darnay BG; Lamothe B; Sun H; Talpaz M; Donato NJ
J Natl Cancer Inst; 2008 Jul; 100(13):926-39. PubMed ID: 18577747
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplant for chronic myeloid leukemia in the imatinib era.
Radich J
Semin Hematol; 2010 Oct; 47(4):354-61. PubMed ID: 20875552
[TBL] [Abstract][Full Text] [Related]
9. Drug developers unveil strategies aimed at imatinib-resistant CML.
Goozner M
J Natl Cancer Inst; 2010 May; 102(9):593-5. PubMed ID: 20421566
[No Abstract] [Full Text] [Related]
10. [Tyrosine kinase inhibitors for the treatment of CML].
Heim D
Ther Umsch; 2006 Apr; 63(4):249-54. PubMed ID: 16689455
[TBL] [Abstract][Full Text] [Related]
11. [Clinical progress in chronic myelogenous leukemia].
Matsunaga T
Rinsho Ketsueki; 2009 Oct; 50(10):1489-99. PubMed ID: 19915358
[No Abstract] [Full Text] [Related]
12. New tyrosine kinase inhibitors in chronic myeloid leukemia.
Martinelli G; Soverini S; Rosti G; Cilloni D; Baccarani M
Haematologica; 2005 Apr; 90(4):534-41. PubMed ID: 15820950
[TBL] [Abstract][Full Text] [Related]
13. Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs?
Jabbour E; Cortes J; Kantarjian H
Oncology (Williston Park); 2007 May; 21(6):653-62; discussion 663-4, 667-8. PubMed ID: 17564324
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate in chronic myeloid leukemia.
Carella AM; Lerma E
Curr Stem Cell Res Ther; 2007 Sep; 2(3):249-51. PubMed ID: 18220908
[TBL] [Abstract][Full Text] [Related]
15. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia.
Wolff NC; Veach DR; Tong WP; Bornmann WG; Clarkson B; Ilaria RL
Blood; 2005 May; 105(10):3995-4003. PubMed ID: 15657179
[TBL] [Abstract][Full Text] [Related]
16. Management of the new patient with CML in chronic phase.
Marin D
Curr Hematol Malig Rep; 2013 Mar; 8(1):37-42. PubMed ID: 23381448
[TBL] [Abstract][Full Text] [Related]
17. [Tyrosine kinase inhibitors in the therapy of chronic myeloid leukaemia].
Grzybowska-Izydorczyk O; Góra-Tybor J; Robak T
Postepy Hig Med Dosw (Online); 2006; 60():490-7. PubMed ID: 17013368
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance.
Bixby D; Talpaz M
Hematology Am Soc Hematol Educ Program; 2009; ():461-76. PubMed ID: 20008232
[TBL] [Abstract][Full Text] [Related]
19. Chronic myelogenous leukemia: role of stem cell transplant in the imatinib era.
Jain N; van Besien K
Hematol Oncol Clin North Am; 2011 Oct; 25(5):1025-48, vi. PubMed ID: 22054733
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate in the treatment of chronic myeloid leukaemia.
Druker BJ
Expert Opin Pharmacother; 2003 Jun; 4(6):963-71. PubMed ID: 12783592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
